Inflammatory Acne Vulgaris

Vyome Therapeutics Begins Dosing in Phase2Trial of VB-1953 in Moderate to Severe Inflammatory Acne Vulgaris

New Delhi, April 25, 2019: Vyome Therapeutics Inc., a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases…

6 years ago